Compact Mass Spectrometer Improves Analysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Compact Mass Spectrometer Improves Analysis


Pharmaceutical Technology
Volume 38, Issue 3, pp. 14

Advion released its latest compact mass spectrometer (CMS), the expression S. The new CMS includes polarity switching during a single analysis to ensure detection of a range of compounds, fast mass scanning (10,000 u/s) for compatibility with UPLC, SFC, and where multiple compounds need to be monitored simultaneously with SIM, as well as higher flow rates of 1-2 mL/min for simpler interfacing with standard chromatographic conditions. The expression S replaces the first generation expression CMS, which will remain available for Advion’s OEM partners. In addition to the hardware advancements, a number of new software features offer additional analysis and data processing options. The software also provides compatibility with DataApex Clarity chromatography software providing seamless integrations with many LC platforms.

Advion

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here